Moderna, Inc. (NASDAQ:MRNA), a Cambridge-based biotechnology leader, specializes in mRNA therapeutics and vaccines, including its flagship COVID-19 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback